NASDAQ: PAVM - PAVmed Inc.

Rentabilité sur six mois: -30.55%
Rendement en dividendes: 0.00%
Secteur: Healthcare

Calendrier des promotions PAVmed Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise PAVmed Inc.

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a patented, single-use, disposable, and minimally invasive surgical device for use in the treatment of carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted next-generation sequencing DNA assay.

plus de détails
Its product pipeline also comprises EsoCure, an esophageal ablation device to treat dysplastic BE; PortIO, an implantable intraosseous vascular access device; NextFlo; and Veris cancer care platform. The company was formerly known as PAXmed Inc. and changed its name to PAVmed Inc. in April 2015. PAVmed Inc. was incorporated in 2014 and is headquartered in New York, New York.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2016-04-28
ISIN US70387R1068
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.pavmed.com
Цена ао 0.815
Changement de prix par jour: -0.6804% (0.7202)
Changement de prix par semaine: +3.22% (0.693)
Changement de prix par mois: -6.33% (0.7636)
Changement de prix sur 3 mois: +10.22% (0.649)
Changement de prix sur six mois: -30.55% (1.03)
Changement de prix par an: -63.69% (1.97)
Evolution du prix sur 3 ans: -29.87% (1.02)
Evolution du prix sur 5 ans: -49.27% (1.41)
Evolution des prix depuis le début de l'année: +10.9% (0.645)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 0.014 10
P/BV -0.006 0
P/E 0.0013 10
EV/EBITDA -0.6905 0
Total: 7.38

Efficacité

Nom Signification Grade
ROA, % 208.29 10
ROE, % -2508.29 0
Total: 3.5

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Devoir

Nom Signification Grade
Debt/EBITDA -0.7162 10
Total: 9.4

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 598900 10
Rentabilité Ebitda, % 185262.5 10
Rentabilité EPS, % -67741.35 0
Total: 6
Plus de détails

Établissements Volume Partager, %
Vanguard Group Inc 302606 3.3
First Manhattan Company 200000 2.18
Blackrock Inc. 74922 0.82
Geode Capital Management, LLC 55078 0.6
Susquehanna International Group, LLP 22561 0.25
Valeo Financial Advisors, LLC 21129 0.23
State Street Corporation 20981 0.23
Northern Trust Corporation 12957 0.14
Wells Fargo & Company 11418 0.12
XML Financial, LLC 10334 0.11



Superviseur Titre d'emploi Paiement Année de naissance
Dr. Lishan Aklog M.D. Chairman & CEO 953.2k 1966 (59 années)
Dr. Brian J. deGuzman M.D. Executive VP, Chief Technology & Compliance Officer 427.6k 1965 (60 années)
Dr. Suman M. Verma M.D., Ph.D. Senior VP of Molecular Genetics & Chief Scientific Officer N/A
Michael Parks Vice President of Investor Relations N/A
Mr. Michael Adam Gordon Executive VP, General Counsel & Secretary 710.5k 1975 (50 années)
Dr. Deepika A. Lakhani Ph.D. Senior VP, Chief Regulatory & Quality Officer N/A
Dr. Victoria T. Lee M.D. Senior VP & Chief Medical Officer N/A
Mr. Shaun M. O'Neill M.B.A. Executive VP & COO 1982 (43 année)

Adresse: United States, New York. NY, 360 Madison Avenue - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.pavmed.com